Update on the Durability and Performance of Collis Gastroplasty For Chronic GERD and Hiatal Hernia Repair At 4-Year Post-Intervention.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084

Informations de publication

Date de publication:
02 2020
Historique:
received: 21 05 2019
accepted: 19 10 2019
pubmed: 27 11 2019
medline: 2 3 2021
entrez: 27 11 2019
Statut: ppublish

Résumé

Collis gastroplasty (CG) remains an important procedure to lengthen the esophagus when indicated in patients undergoing fundoplication for longstanding refractory gastroesophageal reflux disease (GERD) or large hiatal hernias. Concerns over potential sequelae of CG such as dysphagia and worsening heartburn as well as questions regarding the durability of the procedure remain a subject of debate. In this study, 3 and 4-year postoperative data is presented assessing patient quality of life (QOL) measures for those undergoing laparoscopic antireflux surgery (LARS) with and without CG. Comparative review of a prospectively maintained GERD patient database was conducted between patients undergoing LARS with CG versus non-CG (NC) at two institutions between October 2004 and February 2019. Patient demographic, perioperative, and QOL data was analyzed at 3 and 4 years postoperatively using four validated instruments: the Reflux Symptom Index (RSI), Laryngopharyngeal Reflux QOL (LPR-QOL), Swallowing QOL (SWAL), and Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQOL) surveys. A total of 214 CG and 798 NC patients were included in this study. The CG group was older (66.1 ± 12.9 vs. 59.0 ± 14.1, p < 0.001), had a higher frequency of ASA class 3 patients (39.7% vs. 29.7%), and had greater proportion of comorbid disease compared to NG. The groups were parallel in BMI (Collis 28.4 ± 5.2 kg/m Long-term QOL outcomes after laparoscopic CG are comparable to patients treated with fundoplication alone in cases of long-standing GERD and hiatal hernias. Furthermore, CG patients enjoyed equivalent durability of the procedure without risk of subsequent dysphagia. Collis gastroplasty remains an important tool in the armamentarium of foregut surgeons.

Sections du résumé

BACKGROUND
Collis gastroplasty (CG) remains an important procedure to lengthen the esophagus when indicated in patients undergoing fundoplication for longstanding refractory gastroesophageal reflux disease (GERD) or large hiatal hernias. Concerns over potential sequelae of CG such as dysphagia and worsening heartburn as well as questions regarding the durability of the procedure remain a subject of debate. In this study, 3 and 4-year postoperative data is presented assessing patient quality of life (QOL) measures for those undergoing laparoscopic antireflux surgery (LARS) with and without CG.
METHODS
Comparative review of a prospectively maintained GERD patient database was conducted between patients undergoing LARS with CG versus non-CG (NC) at two institutions between October 2004 and February 2019. Patient demographic, perioperative, and QOL data was analyzed at 3 and 4 years postoperatively using four validated instruments: the Reflux Symptom Index (RSI), Laryngopharyngeal Reflux QOL (LPR-QOL), Swallowing QOL (SWAL), and Gastroesophageal Reflux Disease-Health Related Quality of Life (GERD-HRQOL) surveys.
RESULTS
A total of 214 CG and 798 NC patients were included in this study. The CG group was older (66.1 ± 12.9 vs. 59.0 ± 14.1, p < 0.001), had a higher frequency of ASA class 3 patients (39.7% vs. 29.7%), and had greater proportion of comorbid disease compared to NG. The groups were parallel in BMI (Collis 28.4 ± 5.2 kg/m
CONCLUSION
Long-term QOL outcomes after laparoscopic CG are comparable to patients treated with fundoplication alone in cases of long-standing GERD and hiatal hernias. Furthermore, CG patients enjoyed equivalent durability of the procedure without risk of subsequent dysphagia. Collis gastroplasty remains an important tool in the armamentarium of foregut surgeons.

Identifiants

pubmed: 31768831
doi: 10.1007/s11605-019-04438-z
pii: 10.1007/s11605-019-04438-z
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

253-261

Références

J Thorac Cardiovasc Surg. 2008 Oct;136(4):834-41
pubmed: 18954619
Surg Endosc. 2004 Jan;18(1):31-4
pubmed: 14625746
Am J Surg. 1982 Jan;143(1):29-35
pubmed: 7053652
Surgery. 2017 Sep;162(3):568-576
pubmed: 28606726
Dis Esophagus. 2007;20(2):130-4
pubmed: 17439596
Gastroenterol Clin Biol. 1991;15(6-7):512-8
pubmed: 1916129
Dis Esophagus. 2009;22(6):532-8
pubmed: 19222532
Surg Endosc. 2013 Apr;27(4):1334-8
pubmed: 23073687
Arch Otolaryngol Head Neck Surg. 2005 Apr;131(4):315-20
pubmed: 15837899
Ann Surg. 1998 May;227(5):735-40; discussion 740-2
pubmed: 9605665
Arch Surg. 1998 Aug;133(8):867-74
pubmed: 9711961
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Surg Endosc. 2006 Nov;20(11):1702-5
pubmed: 16960664
Arch Surg. 1998 May;133(5):523-8; discussion 528-9
pubmed: 9605915
Ann Surg. 2014 Dec;260(6):1030-3
pubmed: 24487747
Surg Endosc. 2008 Oct;22(10):2123-7
pubmed: 18553196
J Gastrointest Surg. 2012 Jul;16(7):1417-21
pubmed: 22547347
Am J Surg. 1996 May;171(5):477-81
pubmed: 8651389
Ann Thorac Surg. 2011 Nov;92(5):1854-60; discussion 1860-1
pubmed: 21944737
Arch Surg. 2003 Jul;138(7):735-40
pubmed: 12860754
Ann Surg. 2000 Nov;232(5):630-40
pubmed: 11066133
Surg Endosc. 2013 Dec;27(12):4407-8
pubmed: 24196541
Dysphagia. 2002 Spring;17(2):97-114
pubmed: 11956835
Dis Esophagus. 2005;18(5):320-8
pubmed: 16197532
J Voice. 2002 Jun;16(2):274-7
pubmed: 12150380
Eur J Cardiothorac Surg. 2016 Jan;49(1):e22-30
pubmed: 26518379
Surg Endosc. 2012 Mar;26(3):704-13
pubmed: 22002200

Auteurs

Richard Lu (R)

Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, 21401, USA.

Alex Addo (A)

Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, 21401, USA.

Andrew Broda (A)

Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, 21401, USA.

Zachary Sanford (Z)

Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, 21401, USA.

Adam Weltz (A)

Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, 21401, USA.

H Reza Zahiri (HR)

Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, 21401, USA.

Adrian Park (A)

Department of Surgery, Anne Arundel Medical Center, Annapolis, MD, 21401, USA. apark@aahs.org.
Johns Hopkins University School of Medicine, Baltimore, MD, USA. apark@aahs.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH